USCWA
ATHA icon

U.S. Capital Wealth Advisors’s Athira Pharma ATHA Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio ATHA Stock Details ATHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-192
Closed -$609 – 694
2022
Q4 		$609 Buy
+192
New +$609 ﹤0.01% 1561